BG__0000s_0014_HOME

13 March 2018
Pharmablue
About the "Exploitant" status French regulatory authorities require having an « Exploitant » authorized and...
Known as Expanded Access Programs in the US, early access programs (EAP) allow access to...
Rare diseases: At the core of our mission At PharmaBlue, we’ve spent the past decade...